Immunisation in pregnancy: An opportunity for pharmacy to support equity

+Educate
In print
IMMUNISATION

Immunisation in pregnancy: An opportunity for pharmacy to support equity

By Amber Young
Pregnant woman vaccination

Pharmacist Amber Young reviews everything you need to know about immunisation during pregnancy, including the role of pharmacists in improving maternal immunisation coverage

Key points, Maternal immunisation is a safe and important strategy to prevent adverse outcomes in both mothers and their babies. Less than half of all pregnant , Education Blue W/ Grey Background W/ Padding
References
  1. Ministry of Health. Immunisation Handbook 2020. Wellington, NZ: Ministry of Health; 2020. https://www.health.govt.nz/publication/immunisation-handbook-2020
  1. Nowlan M, Willing E, Turner N. Influences and policies that affect immunisation coverage-a summary review of literature. N Z Med J 2019;132(1501):79–88.
  1. Mohammed H, Clarke M, Koehler A, et al. Factors associated with uptake of influenza and pertussis vaccines among pregnant women in South Australia. PLoS One 2018;13(6):e0197867.
  1. Immunisation Advisory Centre. Recommended and funded vaccines during pregnancy. Auckland, NZ: University of Auckland; 2022. https://www.immune.org.nz/resources/written-resources/recommended-and-funded-vaccines-during-pregnancy-%E2%80%93-may-2022
  1. BPACnz. News Update: Pertussis vaccine now subsidised for all pregnant women. 2015. https://bpac.org.nz/bpj/2015/august/news.aspx
  1. World Health Organization. Influenza vaccines: WHO position paper. August 2005. https://www.who.int/publications/i/item/WER8033
  1. Arora M, Lakshmi R. Vaccines - safety in pregnancy. Best Pract Res Clin Obstet Gynaecol 2021;76:23–40.
  1. Reynolds G, Grant N, Thornley S, Hale M. Low uptake of maternal vaccination in notified pertussis cases aged less than 20 weeks. N Z Med J 2017;130(1449):72–74.
  1. Pharmac. Decision to fund the provision of influenza vaccine in pharmacies. 15 March 2017. https://pharmac.govt.nz/news-and-resources/consultations-and-decisions/decision-to-fund-the-provision-of-influenza-vaccine-in-pharmacies/
  1. Unite against COVID-19. COVID-19 vaccine rollout plan. 10 March 2021. https://covid19.govt.nz/news-and-data/latest-news/covid-19-vaccine-rollout-plan/
  1. The ANZIC Influenza Investigators and Australasian Maternity Outcomes Surveillance System. Critical illness due to 2009 A/H1N1 influenza in pregnant and postpartum women: population based cohort study. BMJ 2010;340:c1279.
  1. Rasmussen SA, Jamieson DJ, Uyeki TM. Effects of influenza on pregnant women and infants. Am J Obstet Gynecol 2012;207(3):S3–S8.
  1. Wood N, McIntyre P. Pertussis: review of epidemiology, diagnosis, management and prevention. Paediatr Respir Rev 2008;9(3):201–12.
  1. Yeung KHT, Duclos P, Nelson EAS, Hutubessy RCW. An update of the global burden of pertussis in children younger than 5 years: a modelling study. Lancet Infect Dis 2017;17(9):974–80.
  1. Public Health Surveillance. Pertussis Report May 2019. Wellington, NZ: ESR; 2019. https://surv.esr.cri.nz/surveillance/PertussisRpt.php?we_objectID=4980
  1. Hill L, Burrell B, Walls T. Factors influencing women’s decisions about having the pertussis-containing vaccine during pregnancy. J Prim Health Care 2018;10(1):62–67.
  1. Baxter R, Bartlett J, Fireman B, et al. Effectiveness of vaccination during pregnancy to prevent infant pertussis. Pediatrics 2017;139(5):e20164091.
  1. BPACnz. Pertussis immunisation in pregnancy. 2014. https://bpac.org.nz/bpj/2014/april/pertussis.aspx
  1. Amirthalingam G, Campbell H, Ribeiro S, et al. Sustained effectiveness of the maternal pertussis immunization program in England 3 years following introduction. Clin Infect Dis 2016;63(Suppl 4):S236–43.
  1. Ministry of Health. Pertussis Control Strategies 2015: A consistent approach for New Zealand. Wellington, NZ: Ministry of Health; 2016. https://www.immune.org.nz/resources/written-resources/pertussis-control-strategies-2015-consistent-approach-new-zealand
  1. Kharbanda EO, Vazquez-Benitez G, Lipkind HS, et al. Evaluation of the association of maternal pertussis vaccination with obstetric events and birth outcomes. JAMA 2014;312(18):1897–904.
  1. Petousis-Harris H, Jiang Y, Yu L, et al. A retrospective cohort study of safety outcomes in New Zealand infants exposed to Tdap vaccine in utero. Vaccines (Basel) 2019;7(4):147.
  1. Pool V, Iskander J. Safety of influenza vaccination during pregnancy. Am J Obstet Gynecol 2006;194(4):1200.
  1. Griffin JB, Yu L, Watson D, et al. Pertussis Immunisation in Pregnancy Safety (PIPS) study: A retrospective cohort study of safety outcomes in pregnant women vaccinated with Tdap vaccine. Vaccine 2018;36(34):5173–79.
  1. Giles ML, Krishnaswamy S, Macartney K, Cheng A. The safety of inactivated influenza vaccines in pregnancy for birth outcomes: a systematic review. Hum Vaccin Immunother 2019;15(3):687–99.
  1. Medsafe, Influenza Immunisation in Pregnant Women. 13 December 2018. https://www.medsafe.govt.nz/profs/PUArticles/December%202018/Influenza%20Immunisation%20in%20Pregnant%20Women.htm
  1. Wroe AL, Turner N, Salkovskis PM. Understanding and predicting parental decisions about early childhood immunizations. Health Psychol 2004;23:33–41.
  1. Grant CC, Chen M-H, Bandara DK, et al. Antenatal immunisation intentions of expectant parents: Relationship to immunisation timeliness during infancy. Vaccine 2016;34(11):1379–88.
  1. Wroe AL, Turner N, Salkovskis PM. Understanding and predicting parental decisions about early childhood immunizations. Health Psychol 2004;23(1):33.
  1. Howe A, Best E, Hobbs M. NZ children face a ‘perfect storm’ of dangerous diseases as immunisation rates fall. The Conversation, 10 August 2022. https://theconversation.com/nz-children-face-a-perfect-storm-of-dangerous-diseases-as-immunisation-rates-fall-188157
  1. Howe AS, Pointon L, Gauld N, Paynter J, et al. Pertussis and influenza immunisation coverage of pregnant women in New Zealand. Vaccine 2020;38(43):6766–76.
  1. National Immunisation Register data [unpublished]. Ministry of Health. 2020.
  1. Somerville RL, Grant CC, Grimwood K, et al. Infants hospitalised with pertussis: Estimating the true disease burden. J Paediatr Child Health 2007;43(9):617–22.
  1. WHO. Tailoring Immunization Programmes (TIP). Copenhagen: WHO Regional Office for Europe; 2019. https://apps.who.int/iris/bitstream/handle/10665/329448/9789289054492-eng.pdf
  1. Young A, Charania NA, Gauld N, et al. Knowledge and decisions about maternal immunisation by pregnant women in Aotearoa New Zealand. BMC Health Serv Res 2022;22(1):779.
  1. Litmus Limited. Immunisation for Pregnant Women. Audience research with pregnant women. Wellington, NZ: Ministry of Health; 2015. https://www.health.govt.nz/publication/immunisation-pregnant-women-audience-research-pregnant-women
  1. Gauld N, Martin S, Sinclair O, et al. Mapping the maternal vaccination journey and influencing factors for Māori women in Aotearoa New Zealand: a qualitative study. J Prim Health Care 2022. 30 September online.
  1. Howe AS, Gauld NJ, Cavadino AY, et al. Increasing uptake of maternal pertussis vaccinations through funded administration in community pharmacies. Vaccines 2022;10(2):150.
  1. Gauld N, Martin S, Sinclair O, et al. A qualitative study of views and experiences of women and health care professionals about free maternal vaccinations administered at community pharmacies. Vaccines 2020;8(2):152.
  1. Forster AS, Rockliffe L, Chorley AJ, et al. A qualitative systematic review of factors influencing parents’ vaccination decision-making in the United Kingdom. SSM Popul Health 2016;2:603–12.